scholarly journals A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination

2014 ◽  
Vol 10 (8) ◽  
pp. 2395-2407 ◽  
Author(s):  
Keith S Reisinger ◽  
Sandra J Holmes ◽  
Paola Pedotti ◽  
Ashwani Kumar Arora ◽  
Maria Lattanzi
Keyword(s):  
Influenza Vaccine ◽  
Older Adult ◽  
Pandemic Influenza ◽  
H1n1 Pandemic ◽  
Middle Aged ◽  
Antibody Persistence ◽  
Dose Ranging ◽  
One Year

Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children

Vaccine ◽  
2011 ◽  
Vol 30 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Vladimir Gilca ◽  
Gaston De Serres ◽  
Marie-Eve Hamelin ◽  
Guy Boivin ◽  
Manale Ouakki ◽  
...  
Keyword(s):  
Single Dose ◽  
Influenza Vaccine ◽  
Pandemic H1n1 ◽  
H1n1 Vaccine ◽  
Antibody Persistence ◽  
Trivalent Influenza Vaccine ◽  
One Year

scholarly journals Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age

2014 ◽  
Vol 33 (12) ◽  
pp. e320-e329 ◽  
Author(s):  
Markus Knuf ◽  
Geert Leroux-Roels ◽  
Hans. C. Rümke ◽  
Katia Abarca ◽  
Luis Rivera ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Pandemic Influenza ◽  
H1n1 Pandemic

scholarly journals A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice

PLoS ONE ◽  
2010 ◽  
Vol 5 (5) ◽  
pp. e10492 ◽  
Author(s):  
Julia Steitz ◽  
Peter G. Barlow ◽  
Jaber Hossain ◽  
Eun Kim ◽  
Kaori Okada ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Pandemic Influenza ◽  
Protective Immunity ◽  
H1n1 Pandemic

scholarly journals Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine

PLoS ONE ◽  
2010 ◽  
Vol 5 (12) ◽  
pp. e14270 ◽  
Author(s):  
Yizhuo Sun ◽  
Chao Bian ◽  
Ke Xu ◽  
Weibin Hu ◽  
Tongyan Wang ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Pandemic Influenza ◽  
H1n1 Pandemic ◽  
Immune Protection

Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India

Vaccine ◽  
2014 ◽  
Vol 32 (29) ◽  
pp. 3636-3643 ◽  
Author(s):  
Nagendra R. Hegde ◽  
Deepak Kumar ◽  
P. Panduranga Rao ◽  
P. Krishna Kumari ◽  
Yashpal Kaushik ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Pandemic Influenza ◽  
H1n1 Pandemic ◽  
Preclinical Testing ◽  
A Cell

Dose-range Study of MF59-adjuvanted Versus Nonadjuvanted Monovalent A/H1N1 Pandemic Influenza Vaccine in Six- to Less Than Thirty-Six-month-old Children

2012 ◽  
Vol 31 (7) ◽  
pp. e92-e98 ◽  
Author(s):  
Stan L. Block ◽  
Guillermo M. Ruiz-Palacios ◽  
M. Lourdes Guerrero ◽  
Jenny Beygo ◽  
Victor Sales ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Pandemic Influenza ◽  
Dose Range ◽  
H1n1 Pandemic ◽  
Range Study

scholarly journals Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Jihyun Yang ◽  
Sang-Mu Shim ◽  
Thi Quyen Nguyen ◽  
Eun-Ha Kim ◽  
Kwang Kim ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Glutamic Acid ◽  
Pandemic Influenza ◽  
Cross Reactivity ◽  
H1n1 Pandemic
Sign in / Sign up

Export Citation Format

Share Document